Maxwell M, Shih S D, Galanopoulos T, Hedley-Whyte E T, Cosgrove G R
Department of Neuropathology, Massachusetts General Hospital, Harvard Medical School, Boston 02114-2696, USA.
J Neurosurg. 1998 Mar;88(3):562-9. doi: 10.3171/jns.1998.88.3.0562.
Meningiomas are primarily benign brain tumors thought to arise through multistep tumorigenesis, involving both the activation of oncogenes and the loss of tumor suppressor genes. The recently isolated neurofibromatosis 2 (NF2) tumor suppressor gene has been found to be mutated in a large proportion of meningiomas. Almost all cases of familial meningioma occur in association with NF2. Familial meningioma in isolation from NF2 (sporadic) is exceedingly rare, with only 14 reports since 1959. The authors report the existence of a family lacking any stigmata of NF2, in which two members had spinal meningiomas. Tumor specimens were subjected to immunocytochemical analysis for the NF2 protein product Merlin, which has been implicated in the tumorigenesis of meningioma. Merlin immunoreactivity was present in both tumor specimens, implying that the NF2 tumor suppressor gene was not deleted in these tumors. This supports the hypothesis that a second tumor suppressor gene locus, other than NF2, acts in the formation of familial sporadic meningioma. The results are discussed in the context of putative oncogenic mechanisms of familial meningiomas.
脑膜瘤主要是良性脑肿瘤,被认为是通过多步骤肿瘤发生过程产生的,涉及癌基因的激活和肿瘤抑制基因的缺失。最近分离出的神经纤维瘤病2(NF2)肿瘤抑制基因在很大一部分脑膜瘤中发生了突变。几乎所有家族性脑膜瘤病例都与NF2相关。与NF2无关的家族性脑膜瘤(散发性)极为罕见,自1959年以来仅有14例报道。作者报告了一个没有任何NF2特征的家族,其中两名成员患有脊髓脑膜瘤。对肿瘤标本进行了针对NF2蛋白产物Merlin的免疫细胞化学分析,Merlin与脑膜瘤的肿瘤发生有关。两个肿瘤标本中均存在Merlin免疫反应性,这意味着这些肿瘤中NF2肿瘤抑制基因未缺失。这支持了这样一种假说,即除NF2之外,第二个肿瘤抑制基因位点在家族性散发性脑膜瘤的形成中起作用。本文在家族性脑膜瘤的假定致癌机制背景下对结果进行了讨论。